Abstract
Objective
In 2002 the CDC broadened the pelvic inflammatory disease (PID) diagnostic criteria to increase detection and prevent serious sequelae of untreated PID. The impact of this change on PID detection is unknown. Our objective was to estimate trends in PID diagnosis among adolescent emergency department (ED) patients before and after the revised CDC definition and identify factors associated with PID diagnoses.
Methods
We performed a retrospective repeated cross-sectional study using the National Hospital Ambulatory Medical Care Survey from 2000–2009 of ED visits by 14 to 21 year old females. National estimates of PID rates were calculated. Multivariable logistic regression analyses and tests of trends were performed.
Results
During 2000–2009, of the 77 million female adolescent ED visits, there were an estimated 704,882 (95% CI 571,807, 837,957) cases of PID. Following the revised criteria, PID diagnosis declined from 5.4 cases per 1000 U.S. adolescent females to 3.9 cases per 1000 (p=0.03). In a multivariable model, age ≥17 years (OR 2.14, 95% CI 1.25, 3.64) and Black race (OR 2.04, 95% CI 1.36, 3.07) were associated with PID diagnosis
Conclusions
Despite broadened CDC diagnostic criteria, PID diagnoses did not increase over time. This raises concern about awareness and incorporation of the new guidelines into clinical practice.
Keywords: Pelvic inflammatory disease, Adolescents, Trends
INTRODUCTION
Of the almost 1 million annually diagnosed cases of pelvic inflammatory disease (PID), 20% are estimated to occur in adolescents.[1–3] Although PID is highly preventable with timely diagnosis and treatment of sexually transmitted infections (STI), it is associated with significant morbidity, including infertility, ectopic pregnancy, tubo-ovarian abscesses, pelvic adhesion, dyspareunia, and chronic pelvic pain.[2, 4, 5]
Adolescents with PID are more likely to present to emergency departments (ED) rather than primary care or obstetrics and gynecology clinics.[6] Because abdominal and genitourinary complaints are the most common reasons for ED visits among adolescent females,[7] it is critical that ED providers consider PID as a potential diagnosis when evaluating these patients. However, the diagnosis of PID can be difficult since the clinical presentation of PID may mimic other pelvic and abdominal processes including, but not limited to appendicitis, ovarian torsion, urinary tract infection, and constipation. Given the difficulty of diagnosis and the morbidity associated with disease, the Centers for Disease Control and Prevention (CDC) recommends that health-care providers maintain a low threshold for the diagnosis of PID. In fact, in 2002 the CDC broadened PID diagnostic criteria in an effort to increase diagnostic sensitivity after data suggested that the 1998 CDC criteria would miss more than 15% of true cases of upper genital infection.[8] With this change, the CDC began to recommend the empiric treatment for PID in sexually active women if experiencing lower abdominal pain and if they have cervical motion tenderness or uterine/adnexal tenderness, as opposed to having both present on exam per the prior recommendations.[9]
To our knowledge, there have been no studies that have specifically investigated the impact of the CDC diagnostic change in the ED diagnosis of PID. Therefore, we sought to estimate trends in PID diagnosis among adolescent ED patients before and after the 2002 revised CDC diagnostic guidelines. Our secondary objectives were to determine factors associated with PID diagnosis.
METHODS
Study Design
We conducted a retrospective repeated cross-sectional analysis of the National Hospital Ambulatory Medical Care Survey (NHAMCS) from 2000–2009. This study was considered exempt from formal review by our Institutional Review Board.
Data Source and Study Population
The NHAMCS is an annual, national probability sample survey of hospital EDs conducted by the National Center for Health Statistics (NCHS) branch of the CDC. The survey is conducted during a randomly assigned 4-week data period using a stratified and clustered design for selection of geographic primary sampling units, hospitals within primary sampling units, EDs within hospitals, and patient visits within EDs. Each visit represents a larger number of patients in the population. The NCHS provides probability weights which are equal to the inverse probability of any visit being sampled and allow for the generation of nationally representative estimates using data collected in the NHAMCS.
The eligible study population included all sampled ED visits by females between 14 and 21 years during 2000–2009.
Outcome Measures
Our outcome variable was diagnosis of PID. PID cases were captured by ICD-9 codes of 098.10, 098.16, 098.17, 098.19, 098.86, 099.56, 614.0, 6.14.2, 614.3, 614.5, 614.8, 614.9, 615.0, 615.9 (Appendix). Covariates of interest included year of ED visit, patient age, race and ethnicity, insurance status, disposition, and ED geographic location based on prior literature as well as authors’ hypotheses that these covariates may be related to PID diagnosis. Patient race and ethnicity was categorized as: White (non-Hispanic), Black or African American (Non-Hispanic), Hispanic, or Other. Insurance status was categorized as private, public, or no insurance.
Data Analysis
We used descriptive statistics with survey weighting to perform all analyses. Annual census data was used as the denominator for all rate calculations. Non-parametric trend analysis was used to evaluate trends in PID diagnosis by year and also to compare trends in diagnosis before and after the CDC PID diagnostic criteria change. Finally, logistic regression modeling was performed to identify factors associated with PID diagnosis. For our multivariable model, we included all variables found to have a p-value <0.1 on bivariate analysis.
RESULTS
During 2000–2009, there were 22,866 sampled patient visits, representing 77.3 million female adolescent ED visits. Of these, there were an estimated 704,882 (95% CI 571,807, 837,957) diagnosed cases of PID. PID comprised 1.0% of all female adolescent ED diagnoses and 3.3% of diagnoses among those presenting with lower abdominal pain or genitourinary complaints.
Figure 1 illustrates the incidence of ED diagnosed cases of PID per 1000 persons per year over a United States population of adolescent females based on yearly census data. We found no change in PID diagnosis rates over time (p for trend=0.67). However, when we compared PID visit rates before and after introduction of the 2002 CDC diagnostic guideline change, we found a modest decline, from 5.4 (95% CI 2.7, 8.1) per 1000 persons in 2000–2002 to 3.9 (95% CI 1.5, 6.3) per 1000 persons in 2003–2009 (p=0.03).
Table 1 compares demographics of the total population with the population diagnosed with PID. Table 2 displays the unadjusted and adjusted models for factors associated with PID diagnosis. On bivariate analysis, geographic region was not found to have a statistically significant association with PID diagnosis (p=0.6), and therefore was not included in our final multivariable model. In a fully adjusted model, age 17–21 years (OR 2.14, 95% CI 1.25, 3.64) and Black race (OR 2.04, 95% CI 1.36, 3.07) remained significantly associated with PID diagnosis.
Table 1.
Variable | PID Diagnosed Population | |
---|---|---|
Number of visits | 704,882 | |
Mean Age (years) | 18.7 | |
Race/Ethnicity | White | 48.2 % |
Black | 42.1 % | |
Hispanic | 9.3 % | |
Other | 0.4 % | |
Payer | Private | 27.2 % |
Public | 33.6 % | |
Self-pay/other | 30.1 % | |
Unknown | 9.1 % | |
Geographic Region | Northeast | 13.9 % |
Midwest | 24.4 % | |
South | 49.7 % | |
West | 12.0 % | |
% Hospitalized | 7.7 % |
Table 2.
Variable | Unadjusted Odds (95% CI) | Adjusted Odds (95% CI) | |
---|---|---|---|
Age Category | 14–16 | Ref | Ref |
17–21 | 2.26 (1.34, 3.83) | 2.14 (1.25, 3.64) | |
Race/Ethnicity | Non-Black Race | Ref | Ref |
Black Race | 2.18 (1.47, 3.24) | 2.04 (1.36, 3.07) | |
Insurance Status | Private Insurance | Ref | Ref |
Non-Private Insurance | 1.64 (1.07, 2.51) | 1.39 (0.89, 2.18) | |
ED Disposition | Discharge | Ref | Ref |
Hospital Admission | 1.90 (0.91, 3.99) | 1.99 (0.95, 4.17) |
DISCUSSION
This analysis represents the first population-based assessment of trends in ED based PID diagnosis before and after broadening of the CDC diagnostic criteria in 2002. Despite the broadening of the CDC diagnostic criteria, we did not find an increase in PID diagnosis rates in adolescent ED patients.
There are multiple possible explanations for the decline in PID diagnosis rates we observed among adolescent ED females. One reason might be a decline in Chlamydia trachomatis rates, the organism most commonly associated with PID. However, recent studies have shown that although overall chlamydia prevalence has decreased, there has been no change in the prevalence of chlamydia among females aged 14 to 25 years.[10] Second, perhaps with increased STI screening rates, patients may be treated in other outpatient settings prior to the development of adverse sequelae such as PID. Indeed, other studies have found declining rates of PID with concurrent increase in STI screening rates.[11, 12] However, while the chlamydia screening rates from 2000 to 2010 nearly doubled from 25% to 48% among young women, nonetheless, most are still not receiving screening.[13] Third, perhaps patients may be more likely to undergo PID diagnosis and management in other outpatient settings (e.g. physician offices) rather than EDs. However, Trent and colleagues recently reported that 70% of adolescent PID cases are diagnosed in the ED as compared to other outpatient settings.[6]
Another possible explanation for the decline in ED PID diagnosis rates is that providers are under-detecting PID. The diagnosis of PID can be challenging as the clinical presentation of PID may mimic other pelvic and abdominal processes. One study of pediatric ED providers found that less than 50% of nationally surveyed providers could currently diagnose PID.[14] Another study found that over 50% of adolescent patients diagnosed with cervicitis in the ED actually met diagnostic criteria for PID.[15] These were among patients who actually had pelvic exams performed. As almost 40% of pediatric EM providers report discomfort with the performance of pelvic exams on adolescent females,[14] it is possible that many adolescents with PID are missed due to lack of an appropriate clinical exam. Therefore, despite rates of adolescents reporting sexual experience remaining steady,[16] adolescent STI rates remaining relatively constant, STI screening rates remaining low, and adolescent ED use for sexual health complaints remaining high, it is concerning that ED PID diagnosis rates have declined over the last ten years and may be a result of under-detection. This may have substantial public health consequences as decreased detection and under-treatment of PID will lead to significant morbidity.
We found certain patient demographics to be associated with PID diagnosis. For instance, older patient age was found to be associated with PID diagnosis. This finding is consistent with others that have found older adolescent age to be associated with PID diagnosis.[17] Furthermore, Black race was found to be significantly associated with PID diagnosis. Other studies have reported PID rates to be two to three times higher among black women than among white women.[18] These disparities are consistent with the marked racial disparities observed for the incidence of chlamydia and gonorrhea. However, because of the subjective methods by which PID is diagnosed, which may in itself be prone to racial and socioeconomic biases, racial disparity data should be interpreted with caution.[13, 18]
Several limitations to this study deserve mentioning. First, given that PID is largely a clinical diagnosis and we do not have access to physical exam data, we are unable to validate PID diagnosis. It is also possible that PID cases were under-diagnosed. A recent study found that 52% of adolescent ED patients who met criteria for PID were misdiagnosed as having cervicitis.[15] Additionally, it is possible that due to confidentiality issues, a provider may choose not to provide an ICD-9 diagnosis of PID although PID is clinically suspected and the patient is being treated for PID, and may provide a more vague diagnosis of abdominal pain. This clinical behavior would lead to an underestimation of PID rates. However, it is unlikely that these factors would have changed over time. Furthermore, it is possible that the decline in PID diagnosis rates may be attributable to other residual confounders (e.g. earlier detection and treatment of STIs, increasing outpatient treatment of PID) as well as unknown confounders that cannot be accounted for in this study.
In conclusion, we found a decline in PID diagnosis rates among adolescent ED patients over time despite the broadening of the CDC diagnostic criteria. Whether this result reflects changing epidemiology of PID or possible under-detection of PID should be the subject of future studies. These findings suggest that there may be a need for improvement in the ED identification of adolescents with PID. Prior studies have found that providing brief written information about PID diagnosis and treatment resulted in improved performance in the identification of PID and its treatment. [14, 19] Future studies that evaluate the impact of such interventions and perhaps clinical pathways on a larger scale are warranted and may confer significant public health impact.
IMPLICATIONS AND CONTRIBUTION.
This is the first study to evaluate the impact of the broadened CDC PID diagnostic criteria on adolescent PID diagnosis rates. Rather than finding an increase, we found a decrease in PID diagnoses. This raises concern about awareness and incorporation of the new guidelines into clinical practice.
Acknowledgments
The manuscript has not been published and is not being considered for publication elsewhere, in whole or part, in any language. Dr. Monika Goyal contributed to the conception; study design, data acquisition, analysis, and interpretation; and drafting of the manuscript. Dr. Monika Goyal had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Dr. Adam Hersh contributed to study design; interpretation of data; and provided critical manuscript revisions. Xianqun Luan contributed to data acquisition, analysis, and interpretation. Dr. Russell Localio contributed to study design; data analysis and interpretation of data. Dr. Maria Trent contributed to study design; interpretation of data; and provided critical manuscript revisions. Dr. Theoklis Zaoutis contributed to study conception and design; interpretation of data; and provided critical manuscript revisions. Each author provided approval for the final submitted manuscript.
This work was supported by funding from the National Institutes of Health grant K23 HD070910-01A1 (MKG) and Children’s Hospital of Philadelphia, Department of Pediatrics (MKG). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. Dr. Monika Goyal had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Abbreviations
- PID
Pelvic inflammatory disease
- ED
Emergency department
- STI
Sexually transmitted infections
- CDC
Centers for Disease Control and Prevention
- NHAMCS
National Hospital Ambulatory Medical Care Survey
- NCHS
National Center for Health Statistics
Appendix: Table of ICD-9 codes and associated diagnoses
ICD-9 Code | Associated Diagnosis |
---|---|
098.10 | Gonoccocal infection (acute) of upper genitourinary tract, site unspecified |
098.16 | Gonococcal endometritis (acute) |
098.17 | Gonococcal salpingitis specified as acute |
098.19 | Other gonococcal infection (acute) of upper genitourinary tract |
098.86 | Gonococcal peritonitis |
099.56 | Other venereal diseases due to Chlamydia trachomatis, peritoneum |
614.0 | Acute salpingitis and oophoritis |
614.2 | Salpingitis and oophoritis not specified as acute, subacute, or chonic |
614.3 | Acute parametritis and pelvic cellulitis |
614.5 | Acute or unspecified pelvic peritonitis, female |
614.8 | Other specified inflammatory disease of female pelvic organs and tissues |
614.9 | Unspecified inflammatory disease of female pelvic organs and tissues |
615.0 | Acute inflammatory diseases of uterus, except cervix |
615.9 | Unspecified inflammatory disease of uterus |
Footnotes
None of the authors have any conflicts of interest or disclosures.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Centers for Disease Control and Prevention DoSP, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. [Accessed September 4, 2012.];Pelvic Inflammatory Disease (PID): CDC Fact Sheet. 2011 http://www.cdc.gov/std/pid/STDFact-PID.htm.
- 2.Shafer MA, Sweet RL. Pelvic Inflammatory Disease in Adolescent Females. Adolesc Med. 1990 Oct;1(3):545–564. [PubMed] [Google Scholar]
- 3.Tarr ME, Gilliam ML. Sexually transmitted infections in adolescent women. Clin Obstet Gynecol. 2008 Jun;51(2):306–318. doi: 10.1097/GRF.0b013e31816d7386. [DOI] [PubMed] [Google Scholar]
- 4.Gray-Swain MR, Peipert JF. Pelvic inflammatory disease in adolescents. Curr Opin Obstet Gynecol. 2006 Oct;18(5):503–510. doi: 10.1097/01.gco.0000242952.87125.69. [DOI] [PubMed] [Google Scholar]
- 5.Trent M, Haggerty CL, Jennings JM, et al. Adverse adolescent reproductive health outcomes after pelvic inflammatory disease. Arch Pediatr Adolesc Med. 2011;165(1):49–54. doi: 10.1001/archpediatrics.2010.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Trent M, Ellen JM, Frick KD. Estimating the direct costs of pelvic inflammatory disease in adolescents: a within-system analysis. Sex Transm Dis. 2011;38(4):326–328. doi: 10.1097/OLQ.0b013e3181fc6c65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ziv A, Boulet JR, Slap GB. Emergency department utilization by adolescents in the United States. Pediatrics. 1998;101(6):987–994. doi: 10.1542/peds.101.6.987. [DOI] [PubMed] [Google Scholar]
- 8.Peipert JF, Ness RB, Blume J, et al. Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease. Am J Obstet Gynecol. 2001;184(5):856–863. doi: 10.1067/mob.2001.113847. discussion 863–854. [DOI] [PubMed] [Google Scholar]
- 9.Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR. 2002;51(RR-6):48–52. [PubMed] [Google Scholar]
- 10.Datta SD, Torrone E, Kruszon-Moran D, et al. Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999–2008. Sex Transm Dis. 2012;39(2):92–96. doi: 10.1097/OLQ.0b013e31823e2ff7. [DOI] [PubMed] [Google Scholar]
- 11.Rekart ML, Gilbert M, Meza R, et al. Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. J Infect Dis. 2013;207(1):30–38. doi: 10.1093/infdis/jis644. [DOI] [PubMed] [Google Scholar]
- 12.Scholes D, Satterwhite CL, Yu O, et al. Long-term trends in Chlamydia trachomatis infections and related outcomes in a U.S. managed care population. Sex Transm Dis. 2012;39(2):81–88. doi: 10.1097/OLQ.0b013e31823e3009. [DOI] [PubMed] [Google Scholar]
- 13.Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2009. Atlanta: Department of Health and Human Services; 2010. [Google Scholar]
- 14.Balamuth F, Zhao H, Mollen C. Toward improving the diagnosis and the treatment of adolescent pelvic inflammatory disease in emergency departments: results of a brief, educational intervention. Pediatr Emerg Care. 2010;26(2):85–92. doi: 10.1097/PEC.0b013e3181cdf349. [DOI] [PubMed] [Google Scholar]
- 15.Woods JL, Bailey SL, Hensel DJ, et al. Cervicitis in adolescents: do clinicians understand diagnosis and treatment? J Pediatr Adolesc Gynecol. 2011;24(6):359–364. doi: 10.1016/j.jpag.2011.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Centers for Disease Control and Prevention. Youth Risk Behavior Surveillance - United States, 2011. MMWR. 2012;61(4):24–29. [PubMed] [Google Scholar]
- 17.Kelly AM, Ireland M, Aughey D. Pelvic inflammatory disease in adolescents: high incidence and recurrence rates in an urban teen clinic. J Pediatr Adolesc Gynecol. 2004;17(6):383–388. doi: 10.1016/j.jpag.2004.09.017. [DOI] [PubMed] [Google Scholar]
- 18.Sutton MY, Sternberg M, Zaidi A, et al. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985–2001. Sex Transm Dis. 2005;32(12):778–784. doi: 10.1097/01.olq.0000175375.60973.cb. [DOI] [PubMed] [Google Scholar]
- 19.Trent M, Judy SL, Ellen JM, et al. Use of an institutional intervention to improve quality of care for adolescents treated in pediatric ambulatory settings for pelvic inflammatory disease. J Adolesc Health. 2006;39(1):50–56. doi: 10.1016/j.jadohealth.2005.08.008. [DOI] [PubMed] [Google Scholar]